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ABSTRACT
International Journal of Exercise Science 13(3): 1340-1351, 2020. Currently, there are no established

evidence-based rating of perceived exertion (RPE) targets for physical activity (PA) in pregnant women. Yet, a set
of target heart rate (HR) ranges have been recommended. Using the Borg Scale, we aimed to determine and validate
the RPE target ranges for different PA intensities derived from the recommended HR ranges in the 2019 Canadian
Guideline for PA throughout pregnancy. We assessed 13 pregnant women (age: 31.2 ± 3.5 years; gestational age:
20.5 ± 5.0 weeks) using the following three phases: 1) the incremental submaximal walking test to develop the linear
regression equation; 2) establishment of the RPE targets for light- and moderate-intensity PA; 3) moderate-intensity
exercise session aiming to cross-validate RPE targets in women whose HR ranges were within (Step 1; six
participants; 36 RPE values) or outside (Step 2; seven participants; 42 RPE values) the guideline. Study Phase 1
showed a strong linear relationship between RPE x HR (RPE = -7.370 + 0.155*HR; R2 = 0.863). RPE targets for
pregnant women aged ≤ 29 years are 8-12 (light-intensity) and 12-15 (moderate-intensity), respectively. For women
aged ≥ 30 years, RPE targets are 8-11 (light-intensity) and 11-14 (moderate-intensity), respectively. The crossvalidation suggested no differences between predicted (13.4 ± 0.7) vs. observed RPE (13.3 ± 1.4; p = 0.703) and a
strong % agreement (Step 1 = 80.6%; Step 2 = 73.8%) between observed RPE and its predicted range. Thus, we have
determined pregnancy-specific, evidence-based RPE targets. These RPE targets will help exercise professionals,
other health care providers, and pregnant women to easily monitor exercise intensity during pregnancy to meet
recommended Canadian PA Guideline.
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INTRODUCTION
Recently, the “2019 Canadian Guideline for Physical Activity (PA) throughout Pregnancy” (referred
throughout the text as the Canadian PA Guideline) was released by the Society of Obstetricians
and Gynaecologists of Canada (SOGC) and the Canadian Society for Exercise Physiology
(CSEP). It is an evidence-based guideline substantiated by extensive systematic reviews and
meta-analyses. It also takes into account the user’s point of view, including obstetric care
providers, exercise professionals, researchers, policy organizations, as well as pregnant and
postpartum women, and is founded on feasibility, acceptability, costs, and equity aspects (19).

Int J Exerc Sci 13(3): 1340-1351, 2020
Based on the results of a set of systematic reviews, this current guideline states that pregnant
women should aim to achieve at least 150 min of moderate-intensity PA over three or more days
per week (19). Their findings suggest that meeting the recommendations is associated with
reductions in the odds of developing different pregnancy complications, such as gestational
diabetes mellitus and/or hypertension, as well as pre-eclampsia (12). Although there is a doseresponse relationship between increasing exercise intensity and decreasing odds of developing
depressive symptoms, insulin resistance, gestational diabetes, and hypertension, and preeclampsia (11-13), light-intensity PA has also been shown to be beneficial (19).
The recommendation of moderate-intensity PA, defined as 40-59% HR reserve (HRR)
corresponding to reserve oxygen uptake (10), is comparable to the recent American College of
Sports Medicine (ACSM) heart rate (HR) targets for exercise during pregnancy (2). This
percentage range (i.e., 40-59%) originates from previous ACSM guidelines for prescribing
exercise intensities (3) and follows the position statement on PA and exercise intensity
terminologies (2, 21).
Another method to monitor PA intensity in pregnant women suggested by the Canadian PA
Guideline is by using the “talk test”. For this test, women are advised to remain at a “comfortable
intensity” representing the ability to hold a conversation while physically active. If they cannot
maintain a conversation, the intensity should be reduced (19). The “talk test”, however, is
limited in its scope as it can only measure intensity changes from moderate- to higher intensities,
but fails to take into consideration changes in different exercise and PA intensity ranges (e.g.,
light- to moderate-intensity).
The position statement on physical activity and exercise intensity terminology (21) suggests that
an alternative subjective measure of exercise intensity could be used; rating of perceived
exertion (RPE), also known as Borg RPE scales (6). Of the existing scales, the 15-point scale that
ranges from 6-20, is the most widely used and is recommended for exercise testing and
prescription (6). This scale was developed in an attempt to provide a user-friendly measure that
increases linearly with intensity, similar to the responses of HR (6). Indeed, stress responses
measured by physiological markers (e.g., blood lactate concentrations, HR, oxygen
consumption) (6, 15, 21) increase positively and linearly with PA intensity. These physiological
changes are cognitively perceived as a sensation of physical effort (21), which makes the Borg
RPE scale useful in PA intensity monitoring. According to Borg (5), RPE complements HR
responses to physical effort.
With that in mind, previous guidelines from SOGC/CSEP (14) had included Borg RPE scale
target ranges for moderate-intensity PA (i.e., 12 to 14 on the 6-20 scale); however, the quality of
evidence and classification of recommendations were considered poor, given that no target RPE
values were derived from research in pregnant women. Due to the lack of evidence from the
pregnant population, the current Canadian PA Guideline (19) does not mention RPE as a tool to
monitor exercise intensity. Unlike the Canadian PA Guideline, the last American College of
Obstetricians and Gynecologists (1) exercise guideline did advocate a range of 13-14 on the Borg
RPE scale equivalent to moderate-intensity exercise. The ACOG (1) recommends the use of RPE
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in addition to HR for monitoring PA intensity due to the reported altered HR responses in
pregnant women (18, 24). Nevertheless, ACOG’s suggested RPE ranges are not based on
evidence in pregnant women or on other physiological responses/recommendations for this
population.
The HR targets published by Davenport et al. (10) are considered the up-to-date reference for
light- and moderate-intensity PA during pregnancy and are included in different guidelines for
physical activity throughout pregnancy (2, 19). However, monitoring the proposed HR targets
may present a real-life challenge to women without a HR measuring device. Another issue
related to HR is the variable accuracy of different wearable HR monitors during aerobic exercise
at light- and moderate-intensities (16).
Thus, our goal was to establish RPE target ranges for different PA intensities gleaned from the
recommended HR ranges in the current Canadian PA Guideline (19) for pregnant women. To
determine corresponding RPE ranges to match HR values, we developed an equation that
estimates appropriate RPE target ranges for different PA intensities. We hypothesized that
appropriate RPE ranges would be determined and cross-validated in a simulated bout of
moderate-intensity exercise, due to the high correlation between HR and RPE (6).
METHODS
Participants
Thirteen pregnant women were recruited for participation using social media and flyers.
Eligibility criteria were as follows: maternal age of 18-40 years, carrying a singleton fetus, no
contraindications to exercise, and a self-reported pre-pregnancy body mass index (BMI)
between 18.5 – 29.9 kg/m2, and 13-28 weeks of gestation (2nd trimester of pregnancy). Although
the gestational age range we selected was wide, Pivarnik et al. (23) found no differences in HR
and RPE responses during exercise across this time point (i.e., the 2nd trimester of pregnancy).
Those with gestational diabetes, hypertension, or untreated thyroid disease were excluded. All
experimental procedures were approved by the local Research Ethics Board (H-06-18-634).
Study procedures were explained in person, after which informed written consent was obtained
from all study participants. This research was carried out in accordance with the ethical
standards of the International Journal of Exercise Science (20).
Protocol
The study design is outlined in Figure 1. The procedures are detailed below.
Participants were asked to visit the lab following a minimal 8 h fast and to abstain from exercise
for 12 h before the session. Height and body weight were measured using a Tanita HR-200 wallmounted stadiometer (accuracy: 0.1cm; Lachine, QC) and Tanita BWB-800 scale, respectively.
The study protocol required participants to arrive fasted for a baseline blood draw, followed by
a standardized (~400 kcal) snack before the exercise session. The participants were fasted
overnight as the current study was part of a larger study assessing blood biomarkers in
pregnancy.
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Figure 1. Study design. HR = heart rate; PA = physical activity; RPE = rating of perceived exertion.

Resting HR was determined by obtaining the average HR recorded at 1 min intervals during the
last 5 min of a 10 min seated resting phase.
The first part of the exercise session consisted of an incremental submaximal walking test
conducted using a Woodway Pro XL 27 treadmill (Woodway USA, Waukesha, WI) described as
follows: 3 min warm-up at a speed of 2.0 miles per hours (mph) and an incline of 2.0%. Then,
the incline increased to 6.0%, with speed increasing by 0.2 mph at 1-min intervals. HR was
continuously measured using a Polar V800 watch (Polar Electro Canada, Lachine, QC) until the
target calculated moderate-intensity HR range was reached (i.e., the upper limit of the 40-59%
of HRR range). This target is consistent with the Canadian PA Guideline (19). The following
equation was employed to determine the moderate-intensity target HR range using the
following calculation: %HRR = [(HRmax – resting HR)* %intensity] + resting HR; where HRmax
= 220 – age.
Along with HR monitoring throughout the incremental submaximal walking test, RPE values
were recorded using the 6-20 Borg Scale (6) 15 seconds before the end of each stage of the test.
From the HR data, HR values were pooled at the same time RPE was collected in order to create
the linear regression equations (Study Phase 1) and subsequently develop the RPE targets for
light- and moderate-intensity PA (Study Phase 2).
Moderate-intensity exercise session (Study Phase 3): Once the upper limit of the 40-59% HRR
range was achieved in the incremental submaximal walking test, the participants continued to
exercise at moderate-intensity for 30 min as close as possible to the upper limit of the 40-59%
HRR range using the same treadmill and with continuous measurement of HR as described
above. The speed was adjusted accordingly to ensure that the target moderate-intensity HR
range was maintained. RPE and HR were recorded every 5 min (i.e., 5th, 10th, 15th, 20th, 25th,
and 30th minutes) until the completion of the exercise session. A 30-min moderate-intensity
exercise session was chosen to replicate a suggested bout of prenatal PA (19).
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To cross-validate RPE targets, Study Phase 3 was further divided into two steps (Steps 1 and 2).
Separation of study processes was necessary because some of our participants were found to be
exercising outside of the recommended HR targets based on findings from Davenport et al. (10).
This identification of exercise intensities outside the recommended range is due to differences
in observed resting HR (used to calculate 40-59% HRR) in our study population compared to
those in Davenport et al. (10).
Thus, in Step 1 the observed RPE values obtained from the 5th-30th minutes of the moderateintensity exercise session were compared with the predicted RPE values from the developed
equation (Study Phase 1) for women whose HR ranges were within the guideline
recommendations (n = 6 participants; total of 36 RPE values) according to their individualized
40-59% HRR target ranges (10). In Step 2 of the cross-validation of the RPE targets, we used the
observed RPE values from seven participants whose suggested moderate-intensity HR ranges
fell outside the guideline recommendations. Assuming that the exercise session for this group
was also considered a moderate-intensity exercise bout, we used observed RPE values in the
seven women captured from the 5th-30th minutes (a total of 42 RPE values) of the exercise
session separately.
Statistical Analysis
A power analysis conducted using G*POWER 3.1 (Universitat Kiel, Germany) determined that
a minimum of 11 participants were required in the present study for a power of 80%, an effect
size of 0.7, and an α = 0.05. The effect size of 0.7 was determined based on the results of a large
(n = 2560) (non-pregnant) cohort study (25) examining the association between HR and RPE
during an incremental exercise test.
Data are presented as mean ± standard deviation, and the Shapiro-Wilk normality test was used
to determine if parametric (paired t-test) or non-parametric (Wilcoxon test) tests would be used
in the comparison analysis.
Statistical analysis followed similar procedures described previously by Davenport et al. (8) to
establish the cut-off points for HR described in the Canadian PA Guideline. In Study Phase 1,
linear regression equations were developed for each of the 13 participants. The regression
equations and other linear regression variables were pooled to determine mean values for the
final equation. A one-sample t-test was used to compare mean intercept and slope with the line
of identity (Intercept = 0; Slope = 1) to verify whether HR and RPE were equivalent.
Subsequently, in Study Phase 2, HR targets were pooled from the Canadian PA Guideline (17) and
applied to the equation to determine the RPE targets for light- and moderate-intensity PA,
considering that the incremental submaximal walking test only included these intensity zones.
RPE targets were developed for women aged ≤ 29 years and ≥ 30 years separately, as also
presented in the Canadian PA Guideline for HR targets during PA.
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The final phase of the analysis (Study Phase 3) was the cross-validation of the RPE targets,
separated in two steps. In Step 1, the observed RPE values obtained at 5th, 10th, 15th, 20th, 25th,
and 30th minutes of the moderate-intensity exercise session were compared with the predicted
RPE values from the developed equation (HR x RPE) for women whose HR ranges were within
the guideline recommendations (n = 6 participants; total of 36 RPE values; Wilcoxon test)
according to their individualized 40-59% HRR target ranges (10). We also calculated the
percentage of agreement (% agreement = [n of agreements / total sample size] * 100) between
the observed RPE values and the predicted RPE targets derived from the HR ranges for the
moderate-intensity exercise session (total of 36 RPE values). This percentage value was also
classified according to McHugh (17) to determine the level of agreement (0-4% None; 4-15%
Minimal; 15-35% Weak; 35-63% Moderate; 64-81% Strong; 82-100% Almost Perfect).
In Step 2 of the cross-validation of the RPE targets, we used the observed RPE values from seven
participants whose suggested moderate-intensity HR ranges were outside the guideline
recommendations. Assuming that the exercise session for this group was also considered a
moderate-intensity exercise bout, we used observed RPE values in the seven women captured
at the 5th, 10th, 15th, 20th, 25th, and 30th minutes (total of 42 RPE values) of the exercise session
and analyzed the percentage of agreement described above with the RPE targets derived from
the HR cut-offs.
Participants in Step 1 and 2 of Study Phase 3 were compared with regards their descriptive
characteristics using the Mann-Whitney test or unpaired t-test, according to the normality test
results. For all the inferential analyses performed, significance was set at p < 0.05.
RESULTS
The characteristics of pregnant women participating in the present study, as well as the
subgroup analyzed in the cross-validation procedure, are described in Table 1. The incremental
submaximal walking test lasted, on average, 10 ± 2 min.
The regression equation for HR vs. RPE was significantly different from the line of identity
(slope = 1; intercept = 0), as presented in Table 2. The proportion of variability from one variable
explained by the other was determined according to the coefficient of determination of the
model, which was R2 = 0.863 for the raw analysis and R2 = 0.836 for the adjusted analysis. Other
parameters of the linear regression are described in Table 3 (Study Phase 1).
The RPE targets were calculated by applying the HR values described in the Canadian PA
Guideline in the regression equation developed in the Study Phase 1. The derived RPE targets
for light- and moderate-intensity PA are described in Table 4 (Study Phase 2).
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Table 1. Study population characteristics.
Equation development
(n = 13)
31.2 ± 3.5
20.5 ± 5.0
166.7 ± 5.4
69.6 ± 10.3
5.8 ± 3.9
63.7 ± 9.5
23.7 ± 3.6
81 ± 14.5

Demographics

Cross-validation 1
(n = 6)
33.5 ± 3.3
18.8 ± 5.5
167.7 ± 4.0
70.2 ± 11.0
4.8 ± 4.3
65.4 ± 9.5
23.4 ± 3.9
73 ± 11

Cross-validation 2
(n = 7)
29.3 ± 2.6*
22.0 ± 4.4
165.8 ± 6.5
69.0 ± 10.5
6.7 ± 4.3
62.3 ± 10.0
24.0 ± 3.5
89 ± 14*

Age (years)
Gestational age (weeks)
Height (cm)
Weight at visit (kg)
Gestational weight gain (kg)
Pre-pregnant body weight (kg)
Pre-pregnant BMI (kg·m-2)
Resting HR (bpm)
Incremental submaximal walking test
Speed to reach the upper limit of 40-59%
3.4 ± 0.4
3.7 ± 0.5
3.4 ± 0.3
HRR (mph)
Moderate-intensity exercise session
40% HRR (bpm)
125 ± 9.5
119 ± 6.1
130 ± 9.2*
60% HRR (bpm)
146 ± 7.1
141 ± 4.2
150 ± 6.8*
Note. *p < 0.05. BMI = body mass index; HR = heart rate; HRR = heart rate reserve; bpm = beats per minute.

Table 2. Means and standard deviation for the intercept and slope of linear regression analysis for RPE predicted
from HR (n = 13).
RPE vs. HR
Mean ± SD
p-value for the line of identity
Intercept

-7.370 ± 5.849

0.002a

Slope
0.155 ± 0.050
< 0.001b
Note. RPE = rating of perceived exertion; HR = heart rate; SD = standard deviation. aSignificantly different than 0.
bSignificantly different than 1.

Table 3. R-value, p-value from the correlation, coefficient of determination, adjusted coefficient of determination,
and standard error of estimation derived from the linear regression to predict RPE based on HR.
R-value (correlation)
p-value (correlation)
R2
Adjusted R2
SEE
RPE vs. HR
0.933
0.005
0.863
0.836
Note. RPE = rating of perceived exertion; HR = heart rate; SEE = standard error of estimation.

0.801

Table 4. RPE targets predicted according to the HR targetsa described in the 2019 Canadian Guideline for PA
throughout pregnancy.
Maternal age (years)
Intensity
HR targets (bpm)
RPE targetsb (Borg scale 6-20)
≤ 29

Light

102-124

8-12

Moderate

125-146

12-15

Light
101-120
8-11
Moderate
121-141
11-14
Note. aHR targets were pooled and adapted from Mottola et al.1. bRPE targets were determined based on the
equation RPE = -7.370 + 0.155*HR. bpm = beats per minute; HR = heart rate; RPE = rating of perceived exertion.
≥ 30
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When our equation was used in the first step of cross-validation analyses (36 RPE observations),
predicted RPE (13.4 ± 0.7) based on the HR obtained in the 30-min moderate-intensity exercise
session was not different from the observed RPE (13.3 ± 1.4) obtained throughout the exercise
session (p = 0.703). We also compared the predicted and observed RPE values only in the first
15-min (1st half) as well as in the last 15-min (2nd half of the exercise session). For both first (18
RPE observations) and last half (18 RPE observations) of the exercise session, there was no
difference between predicted and observed RPE values (Predicted RPE = 13.4 ± 0.7; Observed
RPE = 13.6 ± 1.2; p = 0.624 for 1st half and predicted RPE = 13.4 ± 0.7; Observed RPE = 13.0 ± 1.6;
p = 0.372 for 2nd half).
The percentage agreement between the observed RPE and RPE targets for moderate-intensity
exercise (RPE of 12-15 for ≤ 29 years old pregnant women and RPE of 11-14 for ≥ 30 years old
pregnant women; Table 4) was calculated for the six women engaged in Step 1 of crossvalidation (36 RPE observations) and revealed 80.6% agreement (classified as a ‘strong’ level of
agreement). The percentage agreement was also determined for the seven women in Step 2 (42
RPE observations) of cross-validation with 73.8% agreement, classified as a ‘strong’ level of
agreement.
DISCUSSION
An important outcome of the study is the development and cross-validation of RPE ranges for
light- and moderate-intensity PA for pregnant women. For those aged ≤ 29 years, light-intensity
PA RPE targets are 8-12 on the 6-20 Borg RPE scale, whereas moderate-intensity corresponds to
12-15. Women aged ≥ 30 years should associate light-intensity PA to RPE scores of 8-11 and
moderate-intensity to 11-14, using the same scale.
The HR targets published by Davenport et al. (10), considered the up-to-date reference for lightand moderate-intensity PA during pregnancy, are those associated with the exercise guidelines
in this population (2, 19). While HR targets are an excellent tool for those with access to a HR
monitor, this strategy is not realistic for monitoring PA intensity in all women. Additionally,
there are concerns regarding the accuracy and reliability of different commercially-available HR
monitors, specifically during aerobic exercise conducted at light- or moderate-intensities (16).
Although RPE, a relatively simple perceptual tool with high practical application, has
previously been included in pregnancy-related PA guidelines as a surrogate measure for
moderate-intensity PA monitoring, the quality of evidence for its inclusion lacked rigor (14). As
such, our study is the first to address this shortcoming and provide RPE targets for light- and
moderate-intensity exercise during pregnancy. We do not include RPE targets corresponding to
vigorous-intensity PA (i.e., 60-79% HRR) for two reasons. First, the incremental submaximal
walking test used to determine the predictive equation was designed to have women exercise
at the recommended moderate-intensity range. Thus, vigorous-intensity HR and RPE values
were not captured. During incremental exercise tests, including the vigorous-intensity range,
participant data illustrate a change from the linear HR-exercise intensity relationship, referred
to as the HR deflection point (8). The departure from linearity is generally reflected as a concave
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trend in the HR curve (9). However, this curve has a wide range of inter-subject variability,
allowing the observation of not only concave but also convex and linear trends (5).
Consequently, extrapolating RPE values for vigorous-intensity HR targets from light- and
moderate-intensities could be premature.
The second reason as to why vigorous-intensity RPE targets were omitted from our study is that
the Canadian PA Guideline recommends vigorous-intensity PA only in a monitored environment
(19). Additionally, there is still a lack of information regarding the benefits of exercising within
this higher intensity range, especially with-respect-to the upper limit, which prompted the
Canadian PA Guideline to recommend that pregnant women consult their obstetric care provider
before starting a vigorous-intensity exercise regimen (19).
Despite the optimistic results from our cross-validation phase, they do not agree with those
found by O’Neill et al. (22), which showed that HR prediction based on RPE underestimated the
observed HR values in pregnant women. O’Neill’s results can be explained by the predictive
approach taken to calculate HR based on RPE that these authors used. Essentially, they added a
“0” value to the 6-20 RPE Borg Scale, representing participants’ HR. Although Borg (6)
suggested that the 6-20 values corresponded to HR ranges from 60-200 beats·min-1, it was also
mentioned that a given exercise session that evokes a HR of 150 beats·min-1 may be assigned an
RPE of either 13 or 17 as a result of a multitude of physical and emotional factors. Ideally, both
HR and RPE should be used together to monitor exercise intensity (6), which was acknowledged
by O’Neill et al. (22). In lieu of adding a “0” value to the RPE scale to predict HR values, we
followed the same approach (i.e., simple linear regression) as the one used in pregnant women
by Davenport et al. (10) to determine the HR ranges.
The RPE target ranges found in the current study showed an overlap between the upper limit
for light-intensity and the lower limit for moderate-intensity RPE values in both younger (i.e., ≤
29 years; RPE = 12) and older pregnant women (i.e., ≥ 30 years; RPE = 11). These differing results
were observed because the RPE values obtained from the prediction equation were rounded as
a necessity. As 6-20 RPE values are not commonly reported using decimals, we deemed that
rounding was acceptable.
Overall, this study has important strengths. The statistical procedures used to determine
appropriate RPE targets were based on similar methods employed by Davenport et al. (8).
Additionally, the cross-validation (Study Phase 3) was based on a moderate-intensity PA session
with both women who were exercising within the HR guideline targets (i.e., Step 1) and those
exercising outside the HR guideline targets according to their resting HR (i.e., Step 2). The study
also has limitations. Only women in their 2nd trimester were studied, similar to the HR target
ranges described in the Canadian PA Guideline (19), and we cannot assure this will be applicable
in other pregnancy time points (i.e., earlier or later in pregnancy). Also, we included pregnant
women who were classified as normal and overweight, while Davenport et al. (10) included
women categorized as overweight or obese in their study to develop the HR target ranges. The
reason for analyzing both women categorized as normal-weight and overweight in the present
study is that the current Canadian PA Guideline (19) extrapolated the HR target ranges for those
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in all BMI categories. Due to the small sample size (n=9 classified as normal weight and n=4
considered overweight), we could not perform our analysis separately between BMI categories.
On a similar note, the impact of gestational weight gain on these RPE ranges was not assessed
in the present study. Based on self-reported PA questionnaire assessment, we found that many
of our participants reported being quite active (unpublished data), but none of them were
actively engaged in exercise training (i.e., systematic and prescribed training). As this study
included only 13 women, we opted not to include this self-reported data in the analysis since
subjective data have been found to overestimate PA levels in pregnancy (7). One more
shortcoming is that the same set of pregnant women were used in the cross-validation, although
we have changed the exercise modality (i.e., submaximal incremental test to continuous exercise
session). Lastly, vigorous-intensity PA was not examined in our study. More studies are
required to fully understand the benefits of exercising at higher intensities during pregnancy,
although there is evidence showing positive maternal and fetal outcomes (4). Given these
limitations, future studies should examine the influence of pre-pregnancy BMI categories,
gestational weight gain, PA levels, and other exercise modes and intensities on the relationship
between HR and RPE during exercise.
We concluded that RPE ranges for light- and moderate-intensity PA for pregnant women aged
≤ 29 years old should be 8-12 on the 6-20 Borg RPE scale, whereas Borg 12-15 reflects moderateintensity. Women aged ≥ 30 years old should perform light-intensity PA within the range of 811 and moderate-intensity in the range of 11-14 using the same scale. The cross-validation phase
suggested no differences between predicted vs. observed RPE values and a strong percentage
of agreement between the observed RPE and its predicted range. The availability of appropriate
RPE ranges will ultimately guide the monitoring of exercise-intensity by exercise professionals,
researchers, and pregnant women.
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